Search

Author/Creator Wang, Huei

1. Combining High-Sensitivity Troponin With the American Heart Association/American College of Cardiology Cholesterol Guidelines to Guide Evolocumab Therapy. Issue 3 (20th July 2021)

Authors:
Marston, Nicholas A.; Oyama, Kazuma; Jarolim, Petr; Tang, Minao; Sever, Peter S.; Keech, Anthony C.; Lira Pineda, Armando; Wang, Huei; Giugliano, Robert P.; Sabatine, Marc S.; Morrow, David A.
Journal:
Circulation
Issue:
Volume 144:Issue 3(2021)
Page Start:
249
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Design and rationale of the EBBINGHAUS trial: A phase 3, double‐blind, placebo‐controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin background lipid‐lowering therapy—A cognitive study of patients enrolled in the FOURIER trial. Issue 2 (16th February 2017)

Authors:
Giugliano, Robert P.; Mach, Francois; Zavitz, Kenton; Kurtz, Christopher; Schneider, Jingjing; Wang, Huei; Keech, Anthony; Pedersen, Terje R.; Sabatine, Marc S.; Sever, Peter S.; Honarpour, Narimon; Wasserman, Scott M.; Ott, Brian R.
Journal:
Clinical cardiology
Issue:
Volume 40:Issue 2(2017)
Page Start:
59
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Effect of Evolocumab in Patients With Prior Percutaneous Coronary Intervention. (25th February 2022)

Authors:
Furtado, Remo H.M.; Fagundes, Antônio Aurélio; Oyama, Kazuma; Zelniker, Thomas A.; Tang, Minao; Kuder, Julia F.; Murphy, Sabina A.; Hamer, Andrew; Wang, Huei; Keech, Anthony C.; Giugliano, Robert P.; Sabatine, Marc S.; Bergmark, Brian A.
Journal:
Circulation
Issue:
Volume 15:Number 3(2022)
Page Start:
e011382
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Effect of Evolocumab in Patients With Prior Percutaneous Coronary Intervention. (March 2022)

Authors:
Furtado, Remo H.M.; Fagundes, Antônio Aurélio; Oyama, Kazuma; Zelniker, Thomas A.; Tang, Minao; Kuder, Julia F.; Murphy, Sabina A.; Hamer, Andrew; Wang, Huei; Keech, Anthony C.; Giugliano, Robert P.; Sabatine, Marc S.; Bergmark, Brian A.
Journal:
Circulation
Issue:
Volume 15:Number 3(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates. Issue 5 (3rd September 2009)

Authors:
Dore, Robin K; Cohen, Stanley B; Lane, Nancy E; Palmer, William; Shergy, William; Zhou, Lifen; Wang, Huei; Tsuji, Wayne; Newmark, Richard
Journal:
Annals of the rheumatic diseases
Issue:
Volume 69:Issue 5(2010)
Page Start:
872
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Hypocalcaemia in patients with metastatic bone disease treated with denosumab. Issue 13 (September 2015)

Authors:
Body, Jean-Jacques; Bone, Henry G.; de Boer, Richard H.; Stopeck, Alison; Van Poznak, Catherine; Damião, Ronaldo; Fizazi, Karim; Henry, David H.; Ibrahim, Toni; Lipton, Allan; Saad, Fred; Shore, Neal; Takano, Toshimi; Shaywitz, Adam J.; Wang, Huei; Bracco, Oswaldo L.; Braun, Ada; Kostenuik, Paul J.
Journal:
European journal of cancer
Issue:
Volume 51:Issue 13(2015:Sep.)
Page Start:
1812
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Inflammatory and Cholesterol Risk in the FOURIER Trial. Issue 2 (10th July 2018)

Authors:
Bohula, Erin A.; Giugliano, Robert P.; Leiter, Lawrence A.; Verma, Subodh; Park, Jeong-Gun; Sever, Peter S.; Lira Pineda, Armando; Honarpour, Narimon; Wang, Huei; Murphy, Sabina A.; Keech, Anthony; Pedersen, Terje R.; Sabatine, Marc S.
Journal:
Circulation
Issue:
Volume 138:Issue 2(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. LDL-cholesterol lowering with evolocumab, and outcomes according to age and sex in patients in the FOURIER Trial. (5th February 2020)

Authors:
Sever, Peter; Gouni-Berthold, Ioanna; Keech, Anthony; Giugliano, Robert; Pedersen, Terje R; Im, KyungAh; Wang, Huei; Knusel, Beat; Sabatine, Marc S; O'Donoghue, Michelle L
Journal:
European journal of preventive cardiology
Issue:
Volume 28:Number 8(2021)
Page Start:
805
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial. Issue 8 (25th February 2020)

Authors:
Marston, Nicholas A.; Kamanu, Frederick K.; Nordio, Francesco; Gurmu, Yared; Roselli, Carolina; Sever, Peter S.; Pedersen, Terje R.; Keech, Anthony C.; Wang, Huei; Lira Pineda, Armando; Giugliano, Robert P.; Lubitz, Steven A.; Ellinor, Patrick T.; Sabatine, Marc S.; Ruff, Christian T.
Journal:
Circulation
Issue:
Volume 141:Issue 8(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗